Repetitive mild brain trauma accelerates Aβ deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis

Journal of Neuroscience

Volumn 22, Issue 2, 2002, Pages 446-454

  Uryu, Kunihiro ^a   Laurer, Helmut ^a   McIntosh, Tracy ^a   Praticò, Domenico ^a   Martinez, Daniel ^a   Leight, Susan ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Amyloid plaques; APP mice; Brain injury; Cognitive function; Head trauma; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ISOPROSTANE DERIVATIVE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; LIPID PEROXIDATION; MOTOR DYSFUNCTION; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037080159     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-02-00446.2002     Document Type: Article

References (59)

1. Postinjury treatment with magnesium chloride attenuates cortica damage after traumatic brain injury in rats
2. Key factors in Alzheimer's disease: Beta-amyloid precursor protein processing, metabolism and intraneuronal transport
3. Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice
4. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization
5. A controlled cortical impact model of traumatic brain injury in the rat
6. Altered cleavage and secretion of a recombinant beta-APP bearing the Swedish familial Alzheimer's disease mutation
7. Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze
8. Neuronal cytoskeletal changes are an early consequence of repetitive head injury
9. Molecular pathology of head trauma: Altered beta APP metabolism and the aetiology of Alzheimer's disease
10. Head injury and the risk of AD in the MIRAGE study
11. Amyloid, the presenilins and Alzheimer's disease
12. A model for beta-amyloid aggregation and neurotoxicity based on the free radical generating capacity of the peptide: Implications of "molecular shrapnel" for Alzheimer's disease
13. Alzheimer's disease: A study of epidemiological aspects
14. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
15. Identification of the major A beta (1-42)-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
16. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43)
17. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
18. Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes
19. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
20. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family
21. Mild head injury increases the brain's vulnerability to a second traumatic impact
22. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
23. Oxidative alterations in Alzheimer's disease
24. Molecular basis of the neurodegenerative disorders
25. Traumatic brain injury in the rat: Characterization of a midline fluid-percussion model
26. Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model
27. Regulation of amyloid precursor protein cleavage
28. Place navigation impaired in rats with hippocampal lesions
29. Head injury as a risk factor for Alzheimer's disease
30. Twofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury
31. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging
32. Brain trauma in aged transgenic mice induces regression of established abeta deposits
33. Increased vulnerability of NFH-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cortical damage
34. Regulation of APP cleavage by alpha-, beta- and gamma-secretases
35. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome
36. Enduring cognitive, neurobehavioral and histopathological changes persist for up to one year following severe experimental brain injury m rats
37. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias
38. F(2)-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo
39. Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease
40. Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo
41. 2α-VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity
42. Down's syndrome is associated with increased 8,12-iso-iPF2α-VI levels: Evidence for enhanced lipid peroxidation in vivo
43. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis
44. Mutant genes in familial Alzheimer's disease and transgenic models
45. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation
46. BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice
47. Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease
48. Alzheimer's disease as proteolytic disorders: Anabolism and catabolism of beta-amyloid
49. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury
50. Translating cell biology into therapeutic advances in Alzheimer's disease
51. A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects
52. Progressive atrophy and neuron death for one year following brain trauma in the rat
53. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
54. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss
55. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme
56. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging
57. The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient
58. GM1 ganglioside-bound amyloid beta-protein (A beta): A possible form of preamyloid in Alzheimer's disease
59. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)